News | February 09, 2009

Dilon Technologies Leads Molecular Breast Imaging Expansion

February 10, 2009 - Dilon Technologies Inc. said today it had record sales for 2008 highlighted by the strongest fourth quarter in the company's history, achieving a 35 percent increase in sales from 2007 to 2008 as molecular breast imaging gains nationwide exposure and acceptance.

Breast-Specific Gamma Imaging (BSGI) - a molecular imaging procedure, along with breast MRI, are expected to increase at a compound growth rate of 28 percent over the next five years, according to the Millennium Research Group's U.S. Markets for Women's Health Imaging Systems report. It also states that Dilon Technologies is leading the way to global availability of molecular breast imaging. Dilon's cornerstone product, the Dilon 6800 Gamma Camera is a high-resolution, compact gamma camera designed to perform BSGI.

Dilon's molecular imaging technology is already available in Europe, parts of the Asian-Pacific basin, the Caribbean, and soon to be in Latin America. In addition, Dilon continues to pursue new alliances with companies such as Terason (Terason t3000 Ultrasound System) and PenRad (PenRad Mammography Information System) to help deliver advanced diagnostic solutions to doctors and patients.

For more information: www.dilon.com

Related Content

California Women In Favor of Extending State's Breast Density Inform Law
News | Breast Density | June 15, 2018
A recent survey of California women found that 95 percent of respondents want the state’s breast density inform law to...
Women More Likely to Use Other Preventive Health Services Following Mammography
News | Mammography | June 13, 2018
Medicare beneficiaries who undergo breast cancer screening with mammography are more likely than unscreened women to...
Breast imaging technologies have seen a rapid evolution.

Breast imaging technologies have seen a rapid evolution.

Feature | Women's Health | June 05, 2018 | By Jeff Zagoudis
Breast imaging technologies have evolved rapidly in the last two decades to help physicians detect breast cancers at
FDA Issues Proposed Order to Reclassify Certain Radiological Medical Image Analyzers
News | Computer-Aided Detection Software | June 01, 2018
The U.S. Food and Drug Administration (FDA) is issuing a proposed order to reclassify certain radiological medical...
Breast Cancer Survivors Not Getting Recommended Number of Mammograms Post-Surgery
News | Mammography | May 24, 2018
Breast cancer survivors are not getting the recommended level of screening post-surgery, according to a newly-published...
FDA's MQSA Accreditation Bodies Approved for Tomosynthesis Accreditation

Image courtesy of Fujifilm.

Feature | Mammography | May 14, 2018
On April 9, 2018, the U.S. Food and Drug Administration (FDA) announced that all four of its Mammography Quality...
Videos | Breast Imaging | May 08, 2018
ITN Associate Editor Jeff Zagoudis speaks with Karen Hou, M.D., breast radiologist at Northwestern Medicine Central D
Overlay Init